Form D · Biotechnology
Oppilan Pharma Ltd
Altrincham, X0 · CIK 0001693601
Offering snapshot reported Dec 30, 2016 · SEC filing
- Reported sold
- $4.25M Offering amount: $12M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 16, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2016 | Initial | $4,250,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-277436
$3Mil in new money; $500K in notes converted to Series A shares; $750K in notes converted to Series B shares
Source: Form D, filed Dec 30, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Krueger | Director, Executive |
| Raju Mohan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3 Rd Floor 1 Ashley Road
Altrincham, X0, WA14 2DT
Altrincham, X0, WA14 2DT